Literature DB >> 16941315

Descriptive epidemiology and case-control study of patients colonized with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus.

Bryndis Sigurdardottir1, Jeffery Vande Berg, Jianfang Hu, Josiah Alamu, Louise-Anne McNutt, Daniel J Diekema, Loreen A Herwaldt.   

Abstract

BACKGROUND: Patients colonized or infected with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus may be at risk of acquiring vancomycin-resistant S. aureus if the vanA gene is transferred from vancomycin-resistant enterococcus to methicillin-resistant S. aureus.
OBJECTIVE: Our goal was to identify risk factors for cocolonization or coinfection (CC/CI) with vancomycin-resistant enterococcus and methicillin-resistant S. aureus.
DESIGN: We conducted a descriptive, epidemiologic study of all patients with CC/CI identified from January 1998 to May 2003 and a nested case-control study of a cohort of patients hospitalized in the burn and wound unit.
SETTING: We conducted our study in a 813-bed tertiary care university teaching hospital. POPULATION: The study population consisted of patients found to have CC/CI during the study period.
METHODS: Descriptive epidemiologic data were collected from hospital records of all patients identified as having CC/CI. A subset of patients hospitalized in the burn and wound unit were included in a case-control study.
RESULTS: CC/CI was detected in 71% of the patients during a single hospital stay. The burn and wound unit, which does active surveillance for both organisms, and the general medicine unit, which does not do active surveillance for either organism, cared for more than one-half of these patients. Among patients being cared for in the burn and wound unit, having exposure to 2 or more invasive devices (central venous catheters, indwelling urinary catheters, and enteral feeding tubes) and renal insufficiency were independent risk factors for CC/CI.
CONCLUSIONS: Patients with CC/CI are the population at greatest risk for vancomycin-resistant S. aureus colonization or infection. The number of invasive devices to which patients are exposed and, thus, possibly the patients' underlying severity of illness, as well as renal insufficiency, appear to be risk factors for CC/CI.

Entities:  

Mesh:

Year:  2006        PMID: 16941315     DOI: 10.1086/507278

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  4 in total

1.  The epidemiology of methicillin-resistant Staphylococcus aureus on a burn trauma unit.

Authors:  Marin Schweizer; Melissa Ward; Sandra Cobb; Jennifer McDanel; Laurie Leder; Lucy Wibbenmeyer; Barbara Latenser; Daniel Diekema; Loreen Herwaldt
Journal:  Infect Control Hosp Epidemiol       Date:  2012-09-21       Impact factor: 3.254

2.  Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation.

Authors:  K Hayakawa; D Marchaim; P Bathina; E T Martin; J M Pogue; B Sunkara; S Kamatam; K Ho; L B Willis; M Ajamoughli; D Patel; A Khan; K P Lee; U Suhrawardy; K K Jagadeesh; S M L Reddy; M Levine; F Ahmed; A M Omotola; M Mustapha; J A Moshos; M J Rybak; K S Kaye
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-26       Impact factor: 3.267

3.  Determining the clinical significance of co-colonization of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in the intestinal tracts of patients in intensive care units: a case-control study.

Authors:  Young Kyung Yoon; Min Jung Lee; Yongguk Ju; Sung Eun Lee; Kyung Sook Yang; Jang Wook Sohn; Min Ja Kim
Journal:  Ann Clin Microbiol Antimicrob       Date:  2019-10-10       Impact factor: 3.944

4.  Horizontal gene transfers link a human MRSA pathogen to contagious bovine mastitis bacteria.

Authors:  Thomas Brody; Amarendra S Yavatkar; Yong Lin; Jermaine Ross; Alexander Kuzin; Mukta Kundu; Yang Fann; Ward F Odenwald
Journal:  PLoS One       Date:  2008-08-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.